| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/26/2000 | EP0995447A1 Formulation comprising antibacterial substance and antiulcer substance |
| 04/26/2000 | EP0995442A1 Use of milk from equines for the manufacture of a preparation for the treatment of bucco-dental troubles |
| 04/26/2000 | EP0995435A1 Aqueous suspension preparations with excellent redispersibility |
| 04/26/2000 | EP0995434A2 Medicinal aerosol formulations |
| 04/26/2000 | EP0995427A2 O/W emulsions containing green tea extract |
| 04/26/2000 | EP0994887A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 04/26/2000 | EP0994884A1 Diphosphonic acid salts for the treatment of osteoporosis |
| 04/26/2000 | EP0994741A1 Apparatus and methods for dispensing pet care substances |
| 04/26/2000 | EP0994727A1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 04/26/2000 | EP0994726A2 Compositions suitable for delivery of genes to epithelial cells |
| 04/26/2000 | EP0994725A1 Thermodynamic adaptive phased array system for activating thermosensititve liposomes in targeted drug delivery |
| 04/26/2000 | EP0994710A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 04/26/2000 | EP0994703A2 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps |
| 04/26/2000 | EP0994701A1 Block copolymer |
| 04/26/2000 | EP0994700A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/26/2000 | EP0994699A1 Controlled release dosage forms containing water soluble drugs |
| 04/26/2000 | EP0994698A1 Delivery of hypericum perforatum (st. john's wort) in tablet form |
| 04/26/2000 | EP0994697A1 Rapamycin formulations for oral administration |
| 04/26/2000 | EP0994696A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 04/26/2000 | EP0994695A1 Continuous microsphere process |
| 04/26/2000 | EP0994693A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 04/26/2000 | EP0994657A1 Palatable elemental medical food |
| 04/26/2000 | EP0994655A1 Satiety product |
| 04/26/2000 | EP0983037A4 Antifungal nail lacquer and method using same |
| 04/26/2000 | EP0735884B1 Flunisolide aerosol formulations |
| 04/26/2000 | EP0589871B1 Peritoneal induced medicaments |
| 04/26/2000 | EP0511292B1 Polyanhydrides of the oligomerized unsaturated aliphatic acids |
| 04/26/2000 | CN1251573A Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 04/26/2000 | CN1251572A Solid compositions suitable for oral administration composing L-carnitine and alkanoyl-L-carnitine mangesium tartrate |
| 04/26/2000 | CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing |
| 04/26/2000 | CN1251527A Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations |
| 04/26/2000 | CN1251524A Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates |
| 04/26/2000 | CN1251520A Use of sodium channel blocker in manfacture of medicament for preventing optic nerve degeneration associated with glaucoma |
| 04/26/2000 | CN1251388A Micro-capsule peridium growth regulator |
| 04/26/2000 | CN1251312A Stable complex of insoluble chemical compound |
| 04/26/2000 | CN1251310A Chinese medicine for treating hyperosteogeny, arthritis and herniation of cervical disc and prolapse of lumbar intervertebral disc and administration device thereof |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/26/2000 | CN1251306A Process for preparing anti-inflammatory and choleretic granules |
| 04/26/2000 | CN1251305A Novel tortoise-tackohoe soft extract |
| 04/26/2000 | CN1251304A Magnetic anal-sitting of Chinese herbs specially treating anal iching anal relax and sexual impotence |
| 04/26/2000 | CN1251302A Traditional Chinese medicine of compounded chlorophyll for treating vegetative nervous disorder and its producing method |
| 04/26/2000 | CN1251301A Biological capsule and its preparation method |
| 04/26/2000 | CN1251297A Benzimidazole enteric coating preparation and preparing method thereof |
| 04/26/2000 | CN1051716C Somatotropin prolonged release |
| 04/26/2000 | CN1051714C Patent medicine of traditional Chinese medicine and preparation method |
| 04/26/2000 | CN1051713C Shuangling oral solution of antidiarrheal and production technology thereof |
| 04/26/2000 | CN1051710C Complex ant capsule |
| 04/26/2000 | CN1051709C Atomized pudendum-cleaning medicine preparation |
| 04/26/2000 | CN1051708C Maren soft capsule (Chinese medicine) for treating constipation and preparation method thereof |
| 04/26/2000 | CN1051701C Freeze-dried Qingkailing powder for injection |
| 04/26/2000 | CN1051681C Method for producing soybean plant extract powder and use of said powder |
| 04/25/2000 | US6054492 Fluorinated copolymeric pharmaceutical adjuncts |
| 04/25/2000 | US6054488 Or its acid addition salt containing ethanol and surfactantother than acetylated monoglycerides; no change crystalmorphology on storage; redispersible |
| 04/25/2000 | US6054486 Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease |
| 04/25/2000 | US6054485 Eye treatments using synthetic thyroid hormone compositions |
| 04/25/2000 | US6054484 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
| 04/25/2000 | US6054482 Hydrolysis of gabapentin or the lactam to form acid addition salt, conversion to pure compound by ion exchanging; antiepileptic agents |
| 04/25/2000 | US6054462 Intranasal antimigraine compositions |
| 04/25/2000 | US6054446 17-substituted-17-desoxy-1,3,5-estratrienes. |
| 04/25/2000 | US6054421 Medical emulsion lubricant |
| 04/25/2000 | US6054145 Making dosage units using low shear granulation |
| 04/25/2000 | US6054144 Spray drying oryzanol suspended in an aqueous surfactant mixture |
| 04/25/2000 | US6054143 Xylitol delivery |
| 04/25/2000 | US6054142 Biocompatible devices with foam scaffolds |
| 04/25/2000 | US6054140 Long acting injectable parasiticidal composition and the process for its preparation |
| 04/25/2000 | US6054138 Stabilized pseudo-emulsions and their preparation process |
| 04/25/2000 | US6054136 Orally administrable composition capable of providing enhanced bioavailability when ingested |
| 04/25/2000 | US6054119 Preparation used in dental care |
| 04/25/2000 | US6054082 Solidified drug supply for generating inhalable drug particles |
| 04/25/2000 | CA2181241C Process for solubilizing difficultly soluble pharmaceutical actives |
| 04/25/2000 | CA2070095C Microspheres containing biologically-active components, processes for the preparation and uses |
| 04/20/2000 | WO2000022008A1 Polymer combining with phosphoric acid and preparation containing the same |
| 04/20/2000 | WO2000021594A2 Flow resistance modulated aerosolized active agent delivery |
| 04/20/2000 | WO2000021582A1 Coumarin-based or melilot-based transdermal plasters |
| 04/20/2000 | WO2000021578A1 Novel ultrasound contrast agents |
| 04/20/2000 | WO2000021568A1 Fibrin glue as a biological adjuvant |
| 04/20/2000 | WO2000021566A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 04/20/2000 | WO2000021541A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 04/20/2000 | WO2000021540A1 Compositions containing diphosphonic acids |
| 04/20/2000 | WO2000021533A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound |
| 04/20/2000 | WO2000021530A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | WO2000021528A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/20/2000 | WO2000021527A2 Oxaliplatinum preparation packaging |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021521A2 Sertraline oral concentrate |
| 04/20/2000 | WO2000021520A2 Opioid analgesic |
| 04/20/2000 | WO2000021519A1 Drug preparation 'histochrome' for treating acute myocardial infarction and ischaemic heart diseases |
| 04/20/2000 | WO2000021518A1 Drug preparation 'histochrome' for treating ocular conditions |
| 04/20/2000 | WO2000021510A2 Formulations of fexofenadine |
| 04/20/2000 | WO2000021505A2 Composition for the parenteral administration of active agents |
| 04/20/2000 | WO2000021504A1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 04/20/2000 | WO2000021503A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/20/2000 | WO2000021499A1 Solid deodorant composition |
| 04/20/2000 | WO2000021491A1 Stable oil-in-water emulsion, method for preparing same and use in cosmetics and dermatology |
| 04/20/2000 | WO2000021490A1 Use of nanoscale sterols and sterol esters |
| 04/20/2000 | WO2000021487A2 Formoterol polymorphs |
| 04/20/2000 | WO2000021370A1 Oligonucleotide delivery systems for camptothecins |
| 04/20/2000 | WO2000021369A1 Treating hiv with edta |
| 04/20/2000 | WO2000003742A3 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 04/20/2000 | WO2000002999A3 Medium and matrix for long-term proliferation of cells |